secwatch.observer — SEC 8-K summary
======================================

Issuer:     THC Therapeutics, Inc. (—)
CIK:        0001404935
Form:       8-K
Filed at:   2023-10-06T23:59:59+00:00
Accession:  0001477932-23-007445
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.02, 5.02, 5.01
LLM model:  deepseek-v4-flash:cloud@v2

THC Therapeutics CEO resigns; Scott Cox appointed interim CEO; change of control via preferred stock
--------------------------------------------------------------------------------

- Brandon Romanek resigned as CEO on Sept 29, 2023; Scott Cox appointed Interim CEO and board member.
- Cox received 600,000 Series A Preferred shares at $0.30 each, each with 100 votes and convertible to 100 common shares.
- Preferred stock issuance constitutes a change of control of THC Therapeutics.
- Cox has over 20 years experience; currently CEO of Verde Bio Holdings (OTC: VBHI).
- Shares were issued under Section 4(a)(2) and Rule 506(b) exemption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1404935/000147793223007445/0001477932-23-007445-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1404935/000147793223007445/thct_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-23-007445

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer